跳至主要内容
临床试验/NCT03059836
NCT03059836已完成不适用

Effects of n3 PUFA Supplementation on the Attenuation of Muscle Disuse Atrophy in Young Women

McMaster University2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2017年2月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
2
主要终点
Muscle Volume

研究概览

简要总结

This study will examine the influence of n3 PUFA supplementation on the rate of muscle atrophy in women undergoing 2 weeks of unilateral limb immobilization. Assessments in skeletal muscle strength and skeletal muscle volume will also me made before, after and in recovery from immobilization.

详细描述

Biological aging is associated with the loss of skeletal muscle mass and strength resulting in compromised metabolic function and mobility. Throughout life, individuals will also experience periods of reduced physical activity/muscle disuse that independently lower muscle mass and strength accelerating the aging process. The losses in muscle mass with aging and disuse are underpinned by feeding-induced declines in rates of muscle protein synthesis. Thus, strategies to enhance muscle protein synthesis could have clinical implications for those who wish to maintain metabolic health and function during times of muscle disuse.

Supplementation with n3 PUFA-enriched fish oil has been shown to potentiate rates of muscle protein synthesis in response to simulated feeding in both younger and older adults. Fish oil supplementation also has been efficacious in enhancing skeletal muscle strength during a period of resistance exercise training. However, no study has examined the impact of fish oil supplementation to enhance muscle protein synthesis and offset declines in muscle mass/strength during a period of immobilization.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Aged 18-30 years

排除标准

  • Take any analgesic or anti-inflammatory drugs(s), prescription or non-prescription, chronically will be excluded
  • A history of neuromuscular problems or muscle and/or bone wasting diseases
  • Any acute or chronic illness, cardiac, pulmonary, liver, or kidney abnormalities, uncontrolled hypertension, insulin- or non-insulin dependent diabetes or other metabolic disorders-all ascertained through medical history screening questionnaires
  • Use medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications)
  • Fish allergy

研究组 & 干预措施

n3 PUFA

Experimental

Intervention: n3 PUFA (3000mg of Eicosapentaenoic acid per day and 1800mg of Docosahexaenoic acid per day)

干预措施: n3 PUFA-enriched fish oil (Dietary Supplement)

Placebo

Placebo Comparator

Intervention: Organic Sunflower Oil 5000mg per day

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Muscle Volume

时间窗: Baseline (0 days), After (14 days) of unilateral limb immobilization and at 14 days post immobilization

Change in Muscle Volume Measured by Magnetic Resonance Imaging

次要结局

  • Skeletal Muscle Strength(Before (0 days), After (14 days) of unilateral limb immobilization and at 14 days Post immobilization)
  • Muscle Lipid Composition(Baseline (-28 days), and at Before (0 days), After (14 days) of unilateral limb immobilization and at 14 days Post immobilization)
  • Integrated Rates of Muscle Protein Synthesis(Before (0 days), During (0-14 days inclusive), and After (14-28 days inclusive) of unilateral limb immobilization)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Stuart Phillips

Professor

McMaster University

研究点 (2)

Loading locations...

相似试验